Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 10/2002

01-10-2002

Relationship Between Response to Interferon-α and Function of Peripheral Blood Mononuclear Cells in Chronic Hepatitis C Patients

Authors: Fátima Esquivel, Agustín Albillos, Flavio Carrión, Alfredo Prieto, Eduardo Reyes, Belén Martínez-Martín, José Luis Calleja, Guillermo Cacho, Melchor Alvarez-Mon

Published in: Digestive Diseases and Sciences | Issue 10/2002

Login to get access
Metadata
Title
Relationship Between Response to Interferon-α and Function of Peripheral Blood Mononuclear Cells in Chronic Hepatitis C Patients
Authors
Fátima Esquivel
Agustín Albillos
Flavio Carrión
Alfredo Prieto
Eduardo Reyes
Belén Martínez-Martín
José Luis Calleja
Guillermo Cacho
Melchor Alvarez-Mon
Publication date
01-10-2002
Publisher
Kluwer Academic Publishers-Plenum Publishers
Published in
Digestive Diseases and Sciences / Issue 10/2002
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1023/A:1020162605925

Other articles of this Issue 10/2002

Digestive Diseases and Sciences 10/2002 Go to the issue

OriginalPaper

REVIEW: Genetic Bases of Autoimmune Hepatitis

OriginalPaper

CASE REPORT: Therapeutic Efficacy of Granulocyte and Monocyte Adsorption Apheresis in Severe Active Ulcerative Colitis

OriginalPaper

Predictors of Pain Medication Use After Percutaneous Liver Biopsy

OriginalPaper

Effects of Prostaglandin E2 on Gastric Irritant-Induced Apoptosis

OriginalPaper

Lack of Objective Evidence of Efficacy of Laxatives in Chronic Constipation

OriginalPaper

Gastric Mucosa Lesions Induced by Duodenogastric Reflux Increase Penetration of N-[3H]-Methyl-N-Nitro-N-Nitrosoguanidine into Corpus Mucosa of Rats
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits